Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2021-07-07 00:00:00 ET · period of report 2021-07-02 · accession 0001209191-21-045825 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-07 | 2021-07-02 | GMED | Scavilla Daniel T | EVP, Chief Commercial Off | M - OptEx | $25.89 | +100.0K | 50.0K | New | +$2.59M |
| DM | 2021-07-07 | 2021-07-02 | GMED | Scavilla Daniel T | EVP, Chief Commercial Off | S - Sale+OE | $78.41 | -100.0K | 0 | -100% | -$7.84M |
| DM | 2021-07-07 | 2021-07-02 | GMED | Scavilla Daniel T | EVP, Chief Commercial Off | M - OptEx | $0.00 | -100.0K | 30.0K | -77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-07-02 | M | A | 50,000 | $26.27 | 100,000 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-07-02 | M | A | 50,000 | $25.52 | 50,000 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-07-02 | S | D | 99,600 | $78.41 | 400 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
| 4 | Common | Class A Common Stock | 2021-07-02 | S | D | 400 | $78.97 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (Right to buy Class A Common Stock) | 2021-07-02 | M | D | 50,000 | $0.00 | 0 | D | $25.52 · — to 2026-01-25 | 50,000 Class A Common Stock | (F3) These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
| 6 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2021-07-02 | M | D | 50,000 | $0.00 | 30,000 | D | $26.27 · — to 2027-01-30 | 50,000 Class A Common Stock | (F4) These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |